You are here

  • Home
  • Archive
  • Volume 10, Issue 7
  • Toll-like receptor 7/8 agonist R848 alters the immune tumor microenvironment and enhances SBRT-induced antitumor efficacy in murine models of pancreatic cancer

Article metrics

Article menu
Clinical/translational cancer immunotherapy
Original research
Toll-like receptor 7/8 agonist R848 alters the immune tumor microenvironment and enhances SBRT-induced antitumor efficacy in murine models of pancreatic cancer

 

Online download statistics by month:

Online download statistics by month: July 2022 to September 2025

AbstractFullPdf
Jul 2022464478167
Aug 2022345349130
Sep 2022265279140
Oct 202220321180
Nov 202214414775
Dec 202210310628
Jan 202310610759
Feb 202310510758
Mar 202310010049
Apr 2023787837
May 2023969844
Jun 202310010351
Jul 202310911562
Aug 2023879045
Sep 2023626223
Oct 2023939459
Nov 202311611754
Dec 2023146147145
Jan 202411311488
Feb 202411111265
Mar 2024158158109
Apr 202413613696
May 202418418489
Jun 202410710782
Jul 202413313680
Aug 2024818063
Sep 2024108109313
Oct 2024949758
Nov 2024153156114
Dec 2024228230136
Jan 202514714799
Feb 2025197197125
Mar 2025164165113
Apr 2025164166118
May 2025191192139
Jun 202512312471
Jul 2025110
Aug 2025110
Sep 2025330
Total531954033264